Covira Surgical

Covira is microbiome-focused company built upon on the life’s work of Dr. John Alverdy, MD, a world authority on the molecular basis of post-surgical infections. Covira’s lead asset (CS-0003) modulates bacterial virulence and restores microbial communities to prevent post-surgical infection.

Covira on the Move

Previous
Previous

Alyra Therapeutics

Next
Next

In Transcription